Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

Lung cancer is one of the malignant tumors with the highest incidence and mortality in the
world. The overall five-year survival rate of lung cancer is relatively lower than many leading …

Importance Lung cancer is the leading cause of cancer-related death in the US. Objective To
review the evidence on screening for lung cancer with low-dose computed tomography …

In the past decade, the introduction of molecularly targeted agents and immune-checkpoint
inhibitors has led to improved survival outcomes for patients with advanced-stage lung …

Importance Pulmonary nodules are identified in approximately 1.6 million patients per year
in the US and are detected on approximately 30% of computed tomographic (CT) images of …

Effective screening modalities are currently available for only a small subset of cancers, and
they generally have suboptimal performance with complicated procedures. Therefore, there …

The Fleischner Society Guidelines for management of solid nodules were published in
2005, and separate guidelines for subsolid nodules were issued in 2013. Since then, new …

Background Lung cancer is a major health problem. CT lung screening can reduce lung
cancer mortality through early diagnosis by at least 20%. Screening high-risk individuals is …

Lung cancer screening with low-dose CT can save lives. This European Union (EU) position
statement presents the available evidence and the major issues that need to be addressed …

Lung cancer is the leading cause of cancer-related mortality in the United States and
worldwide. Early detection of lung cancer is an important opportunity for decreasing …